Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001193125-26-355502

President and CEO sold 48,199 shares at $20.33 ($979,886)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Patel Sanjiv · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-17 Sale : show line 1 in the form 10b5-1 −48,199 $20.33 $979,886 567,699 D
Open-market sales · 48,199 sh · avg $20.33 · $979,886
Loading xslF345X06/ownership.xml…